HuGE Literature Finder
Records
1
-
7
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. The New England journal of medicine 2016 Jun 374 (26): 2530-41. Gotlib Jason, Kluin-Nelemans Hanneke C, George Tracy I, Akin Cem, Sotlar Karl, Hermine Olivier, Awan Farrukh T, Hexner Elizabeth, Mauro Michael J, Sternberg David W, Villeneuve Matthieu, Huntsman Labed Alice, Stanek Eric J, Hartmann Karin, Horny Hans-Peter, Valent Peter, Reiter Andre |
Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer. Expert review of clinical pharmacology 2015 Nov 1-11. Krajewska Jolanta, Olczyk Tomasz, Jarzab Barba |
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study. Journal of cancer research and clinical oncology 2015 Nov 141 (11): 2047-60. Hochhaus Andreas, Baccarani Michele, Giles Francis J, le Coutre Philipp D, Müller Martin C, Reiter Andreas, Santanastasio Helene, Leung Mimi, Novick Steven, Kantarjian Hagop |
Interleukin-7 receptor gene polymorphism at +1237 locus and its effect on susceptibility to opportunistic infections among HIV and AIDS patients in Limpopo Province, South Africa. Genetics and molecular research : GMR 2014 13 (4): 8757-66. Samie A, Moloro G T, Nangammbi T |
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC cancer 2012 12 (1): 107. Rutkowski Piotr, Bylina El?bieta, Klimczak Anna, Switaj Tomasz, Falkowski S?awomir, Kroc Jacek, Lugowska Iwona, Brzeskwiniewicz Magdalena, Melerowicz Wojciech, Osuch Czes?aw, Mierzejewska Ewa, Wasielewski Kacper, Wo?niak Agnieszka, Grzesiakowska Urszula, Nowecki Zbigniew I, Siedlecki Janusz A, Limon Janu |
Imatinib mesylate in thymic epithelial malignancies. Cancer chemotherapy and pharmacology 2011 (2): 309-15. Palmieri Giovannella, Marino Mirella, Buonerba Carlo, Federico Piera, Conti Salvatore, Milella Michele, Petillo Luigi, Evoli Amelia, Lalle Maurizio, Ceribelli Anna, Merola Gerardina, Matano Elide, Sioletic Stefano, De Placido Sabino, Di Lorenzo Giuseppe, Damiano Vincen |
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15 (22): 7061-8. Hong David S, Sebti Said M, Newman Robert A, Blaskovich Michelle A, Ye Lei, Gagel Robert F, Moulder Stacy, Wheler Jennifer J, Naing Aung, Tannir Nizar M, Ng Chaan S, Sherman Steven I, El Naggar Adel K, Khan Rabia, Trent Jon, Wright John J, Kurzrock Razel |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: